These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8221707)

  • 1. Effect of nicardipine on essential tremor: brief report.
    García Ruiz PJ; García de Yébenes Prous J; Jimenez Jimenez J
    Clin Neuropharmacol; 1993 Oct; 16(5):456-9. PubMed ID: 8221707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicardipine versus propranolol in essential tumor.
    Jiménez-Jiménez FJ; Garcia-Ruiz PJ; Cabrera-Valdivia F
    Acta Neurol (Napoli); 1994 Aug; 16(4):184-8. PubMed ID: 7856472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of propranolol in head tremor: quantitative study following single-dose and sustained drug administration.
    Calzetti S; Sasso E; Negrotti A; Baratti M; Fava R
    Clin Neuropharmacol; 1992 Dec; 15(6):470-6. PubMed ID: 1477848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicardipine in severe hypertension: oral therapy following intravenous treatment.
    Wallin JD; Bienvenu GS; Cook E; Laddu A; Turlapaty P; Clifton GG
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):14-9. PubMed ID: 2303309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effects of parenteral nicardipine alone and in combination with captopril.
    Conrad KA; Fagan TC; Mayshar P; Davis TP; Johnson DG
    Clin Pharmacol Ther; 1987 Jul; 42(1):113-8. PubMed ID: 3297467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a single oral dose of propranolol on essential tremor: a double-blind controlled study.
    Calzetti S; Findley LJ; Gresty MA; Perucca E; Richens A
    Ann Neurol; 1983 Feb; 13(2):165-71. PubMed ID: 6338809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twice-daily nicardipine in the treatment of essential hypertension.
    Charlap S; Kimmel B; Laifer L; Weinberg P; Singer M; Lazar E; Saltzberg S; Dorsa F; Kafka K; Strom J
    J Clin Hypertens; 1986 Sep; 2(3):271-7. PubMed ID: 3537214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor.
    Gironell A; Kulisevsky J; Barbanoj M; López-Villegas D; Hernández G; Pascual-Sedano B
    Arch Neurol; 1999 Apr; 56(4):475-80. PubMed ID: 10199338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicardipine versus nifedipine: multicentre controlled trial in essential hypertension.
    Rumboldt Z; Stojanova D; Drinovec J; Marinković M; Nesović M; Srbinovski M; Bagatin J; Nikodijević B; Stalc A
    Int J Clin Pharmacol Res; 1988; 8(6):393-400. PubMed ID: 3075601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicardipine improves myocardial perfusion in systemic sclerosis.
    Kahan A; Devaux JY; Amor B; Menkes CJ; Weber S; Venot A; Guerin F; Degeorges M; Roucayrol JC
    J Rheumatol; 1988 Sep; 15(9):1395-400. PubMed ID: 3264339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of timolol and atenolol on benign essential tremor: placebo-controlled studies based on quantitative tremor recording.
    Dietrichson P; Espen E
    J Neurol Neurosurg Psychiatry; 1981 Aug; 44(8):677-83. PubMed ID: 7028921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind placebo-controlled crossover study of oral nicardipine in the treatment of Raynaud's phenomenon.
    Wollersheim H; Thien T
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):813-8. PubMed ID: 1725892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise.
    Danielsson A; Bjerle P; Ek B; Steen L; Suhr O
    Eur J Clin Pharmacol; 1987; 33(1):15-20. PubMed ID: 3319637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled multicenter double-blind trial of nicardipine in the treatment of primary Raynaud phenomenon. French Cooperative Multicenter Group for Raynaud Phenomenon, Paris, France.
    Am Heart J; 1991 Jul; 122(1 Pt 2):352-5. PubMed ID: 2053556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicardipine in the treatment of Raynaud's phenomenon: a randomized double-blind trial.
    Kahan A; Amor B; Menkès CJ; Weber S; Guérin F; Degeorges M
    Angiology; 1987 Apr; 38(4):333-7. PubMed ID: 3555175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic effect of nicardipine on left ventricular function in systemic sclerosis.
    Kahan A; Devaux JY; Amor B; Menkès CJ; Weber S; Guérin F; Venot A; Strauch G
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):249-53. PubMed ID: 1689420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some effects of prolonged treatment with nicardipine in chronic bronchial asthma.
    Gianotti A; Bottino G; Moscatelli P
    Curr Med Res Opin; 1987; 10(6):422-6. PubMed ID: 3568752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of nicardipine in angina pectoris.
    Thomas MG; Sander GE; Given MB; Quiroz AC; Roffidal LE; Giles TD
    J Clin Pharmacol; 1990 Jan; 30(1):24-8. PubMed ID: 2406298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of nicardipine, a new calcium channel blocker, with nifedipine in the treatment of mild to moderate essential hypertension.
    Armstrong C; Garnham J; Blackwood R
    Postgrad Med J; 1987 Jun; 63(740):463-6. PubMed ID: 3432173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term systemic arterial blood pressure control with nicardipine.
    Castle CH; Wolbach RA
    Am J Cardiol; 1989 Oct; 64(15):35H-41H. PubMed ID: 2679036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.